Zimmer Biomet's mymobility is recognized as "The Care Management Initiative of the Year" by the 2022 Healthcare Asia Medtech Awards
PR95632
SINGAPORE, April 28, 2022 /PRNewswire=KYODO JBN/ --
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology
leader, today announced that the company's mymobility(R) digital care
management platform won "The Care Management Initiative of the Year" award at
this year's Healthcare Asia Medtech Awards.
mymobility(R) is a digital care management platform that uses iPhone(R) and
Apple Watch(R) or Android devices to help surgeons to deliver support and
guidance to their patients, as well as to assist patients to prepare for joint
replacement, by providing the patient the ability to take an active role in
their personal care and recovery process. The app contains personalised care
plans connecting patients with their orthopaedic surgeon and health
practitioners before and after the surgical implantation. Patients have access
to educational content, information on exercises and frequently asked questions
on personal care to optimize their recovery from the surgery.
"We are absolutely delighted to be recognized by Healthcare Asia for the second
consecutive year for our ZBEdge(TM) Connected Intelligence Suite," said Sang
Yi, Group President Zimmer Biomet Asia Pacific. "As a result of the pandemic,
the healthcare industry had to immediately adapt and act in response to an
unprecedented situation. mymobility(R) has enabled patients to receive support
and guidance through a connected experience."
mymobility(R) is part of Zimmer Biomet's ZBEdge(TM) Connected Intelligence
Suite of digital and robotic technologies designed to deliver actionable
insights with the goal of improving patient outcomes using data-powered
clinical insights.
"Innovation has been key to Zimmer Biomet's growth, and we will continue to
invest in new technologies that enable us to stay true to our mission to
alleviate pain and improve the quality of life for people around the world,"
Sang Yi added.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive
portfolio designed to maximize mobility and improve health. We seamlessly
transform the patient experience through our innovative products and suite of
integrated digital and robotic technologies that leverage data, data analytics
and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is
positioned to deliver the highest quality solutions to patients and providers.
Our legacy continues to come to life today through our progressive culture of
evolution and innovation.
For more information about our product portfolio, our operations in 25+
countries and sales in 100+ countries or about joining our team, visit
www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at
www.twitter.com/zimmerbiomet .
SOURCE: Zimmer Biomet
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。